Estimating the long-term risk of recurrence in patients receiving HER2-targeted agents in HER2+early-stage breast cancer (ESBC)David L. Veenstra,Nathaniel Hendrix,Chantal M. Dolan,Kathryn A. Fisher,Deepa Lalla,Nina Oestreicher,Adam BrufskyCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要